Stock Earnings

Question 1

What are China Traditional Chinese Medicine Holdings Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), China Traditional Chinese Medicine Holdings Co Ltd has a total asset of $35,063, Net profit of $54

Question 2

What are the key financial ratios for CHIZF?

Accepted Answer

China Traditional Chinese Medicine Holdings Co Ltd's Current ratio is 2.52, has a Net margin is 0.32, sales per share of $3.27.

Question 3

How is China Traditional Chinese Medicine Holdings Co Ltd's revenue broken down by segment or geography?

Accepted Answer

China Traditional Chinese Medicine Holdings Co Ltd largest revenue segment is Yi Fang, at a revenue of 6,086,135,758 in the most earnings release.For geography, China is the primary market for China Traditional Chinese Medicine Holdings Co Ltd, at a revenue of 17,786,632,186.

Question 4

Is China Traditional Chinese Medicine Holdings Co Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, China Traditional Chinese Medicine Holdings Co Ltd has a net profit of $54

Question 5

Does China Traditional Chinese Medicine Holdings Co Ltd have any liabilities?

Accepted Answer

yes, China Traditional Chinese Medicine Holdings Co Ltd has liability of 13,859

Question 6

How many outstanding shares for China Traditional Chinese Medicine Holdings Co Ltd?

Accepted Answer

China Traditional Chinese Medicine Holdings Co Ltd has a total outstanding shares of 5,035.8

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	15,587	16,509	18,121	14,304	19,052	14,806
Revenue Growth (YoY)	-9%	-9%	27%	-25%	28.99%	3%
Cost of Revenue	8,157	8,653	8,847	7,105	7,223	5,680
Gross Profit	7,429	7,856	9,274	7,198	11,829	9,126
Selling, General & Admin	6,402	6,582	7,455	5,559	8,570	6,294
Research & Development	584	596	685	611	694	550
Operating Expenses	6,805	7,104	7,924	6,023	9,118	6,611
Other Non Operating Income (Expenses)	-24	-24	-29	-19	-18	--
Pretax Income	-219	163	1,224	840	2,520	2,230
Income Tax Expense	115	142	-171	119	396	369
Net Income	-264	54	1,285	764	1,932	1,663
Net Income Growth	-129%	-96%	68%	-60%	16%	5%
Shares Outstanding (Diluted)	5,035.8	5,035.8	5,035.8	5,035.8	5,035.8	5,035.8
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	-0.05	0.01	0.25	0.15	0.38	0.33
EPS Growth	-129%	-96%	68%	-60%	16%	5%
Free Cash Flow	--	2,071	680	565	-81	-1,023
Free Cash Flow Per Share	--	0.41	0.13	0.11	-0.01	-0.2
Gross Margin	47.66%	47.58%	51.17%	50.32%	62.08%	61.63%
Operating Margin	4%	4.54%	7.44%	8.2%	14.22%	16.97%
Profit Margin	-1.69%	0.32%	7.09%	5.34%	10.14%	11.23%
Free Cash Flow Margin	--	12.54%	3.75%	3.94%	-0.42%	-6.9%
EBITDA	--	1,881	2,483	2,273	3,559	3,198
EBITDA Margin	--	11.39%	13.7%	15.89%	18.68%	21.59%
D&A For EBITDA	--	1,130	1,133	1,099	849	684
EBIT	624	751	1,350	1,174	2,710	2,514
EBIT Margin	4%	4.54%	7.44%	8.2%	14.22%	16.97%
Effective Tax Rate	-52.51%	87.11%	-13.97%	14.16%	15.71%	16.54%

China Traditional Chinese Medicine Holdings Co Ltd (CHIZF) Price

CHIZF Stock Price Chart

CHIZF Income

Follow-Up Questions